HCAT · NASDAQ · Medical - Healthcare Information Services

Health Catalyst (HCAT)

Connects healthcare data, applications, and expert services for provider improvement work.

$1.89
After hours+0.01 (+0.48%)
At close$1.88(+3.92%)
Loading prices…

Health Catalyst, Inc.HCAT
Health Care

Pairs the Ignite cloud platform with analytics applications and professional services for healthcare providers. Revenue is split between Technology and Professional Services, and execution is shaped by the Ignite migration, Project Nexus, and the pending Vitalware divestiture.

Built for healthcare providers from a South Jordan, Utah base, the solution combines Health Catalyst Ignite, analytics applications, and professional services. Ignite is a cloud-based ecosystem for analytics, app development, interoperability, and organizing data from disparate healthcare systems.

Applications span Clinical Improvement, Revenue & Cost Improvement, Ambulatory Operations, Measures & Registries, and Data & Analytics. Services add data engineering, implementation, governance, education, tech-enabled managed services, and domain expertise.

Sales are concentrated in Technology and Professional Services, with platform clients and app clients using different parts of the solution. Current execution depends on completing the Ignite migration, absorbing Project Nexus operating-model changes, relying on third-party infrastructure including Microsoft Azure, and managing the signed but not closed Vitalware divestiture.

Company facts

CEOBen Albert
ListedJul 25, 2019
ExchangeNASDAQ
HeadquartersSouth Jordan, UT
CountryUnited States
Employees1,200
CIK0001636422
ISINUS42225T1079

Market cap$133.7M
EPS (ttm)−$3.68
P/E (ttm)−0.4918
ROE-129.7%
P/B1.33
P/S0.4577
Dividend yieldDiv yield
Beta1.37vs XLV 0.80

Price target$1.75−6.4%Average of 22 analysts
ConsensusBuy11 of 22 analysts
Ratings

Target rangeAs of Sep 22, 2026

Latest analyst notes

DateFirmActionPriorCurrent
Aug 21, 2026Canaccord GenuityDowngrade
Rating: Buy
Rating: Hold
Aug 20, 2026Canaccord GenuityTarget
Target: $3
Target: $1.80
Jul 21, 2026Canaccord GenuityReiterate
Rating: Target: $2
Rating: BuyTarget: $3
Jun 26, 2026Wells FargoReiterate
Rating: Target:
Rating: Equal WeightTarget: $1.75
May 12, 2026StephensTarget
Target: $5
Target: $1.75

Next report
Nov 9, 26
in 48 days
EPS estimate
−$0.02
Revenue estimate
$55.4M
Fiscal quarter
Q3 FY26

EPSReportedEstimate

Feb '25May '25Aug '25Nov '25Mar '26May '26Aug '26Nov '26
Reported$0.04$0.01$0.04$0.06$0.08$0.02$0.04Pending
Estimate$0.11$0.01$0.03$0.05$0.09$0.01$0.03−$0.02
Surprise−63.6%0.0%+33.3%+20.0%−11.1%+100.0%+33.9%

RevenueReportedEstimate

Feb '25May '25Aug '25Nov '25Mar '26May '26Aug '26Nov '26
Reported$79.6M$79.4M$80.7M$76.3M$74.7M$70.8M$70.5MPending
Estimate$79.6M$79.2M$85.1M$74.1M$74.0M$69.2M$69.1M$55.4M
Surprise0.0%+0.3%−5.2%+3.0%+1.0%+2.2%+2.0%
Estimate−$0.02
ReportedDue Nov 9, 2026
Estimate$55.4M
ReportedDue Nov 9, 2026
View details

Debt to equity168.60%
Current ratio270.20%

ProfitabilityRevenueNet incomeNet margin

Q3 FY24Q4 FY24Q1 FY25Q2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26
Revenue$76.4M$79.6M$79.4M$80.7M$76.3M$74.7M$70.8M$70.5M
Net income−$14.7M−$20.7M−$23.7M−$41.0M−$22.2M−$91.0M−$111.0M−$40.5M
Net margin0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%

GrowthOperating income

Q3 FY24Q4 FY24Q1 FY25Q2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26
Operating income−$13.7M−$17.5M−$20.2M−$37.1M−$17.5M$3.3M−$6.7M−$36.5M
YoY growthLoss narrowedLoss narrowedLoss narrowedLoss widenedLoss widenedTurned profitLoss narrowedLoss narrowed

Balance sheet, Jun 30, 2026Cash & short-term investments $103.4M · Total debt $170.0M · Total assets $358.6M · Shareholders' equity $100.8M

Revenue
$70.5M
Operating income
−$36.5M
Net income
−$40.5M
View details

No dividends on record.

Institutions70.25%52.87M shares
137 holders · as of Jun 30, 2026
Insiders26.59%20.01M shares
19 holders · as of Sep 16, 2026
Other3.16%2.38M shares
remainder

75.26M company shares as of Sep 22, 2026 · institutions as of Jun 30, 2026 · holders as of their latest filing

Top shareholders13F · 13D/G · Form 4

HolderStakeSharesDate
First Light Asset Management, LLCInstitution
17.02%12.81Mas of Jun 30, 2026
Mathew Paul ArensInsiderdirector, 10 percent owner
14.56%10.96Mfiled Dec 3, 2025
CDC Financial, Inc.Institution
9.42%7.09Mas of Jun 30, 2026
Stoney Lonesome HF LPInstitution
8.08%6.08Mfiled May 15, 2026
Palogic Value Management, L.P.Institution
6.54%4.92Mas of Jun 30, 2026

Insider tradesForm 4

DateInsiderRoleSharesAvg price
Sep 14, 2026Simeon Kohldirector, officer: Chief Executive Officer+59,000$1.79
Dec 4, 2025Julie Larson-Greendirector−47,997$2.67
Dec 5, 2025Benjamin Landryofficer: General Counsel−27,425$2.64
View details

  • Oracle

    EHR-adjacent data platform, analytics, and population-health rival

  • UnitedHealth Group

    Optum Insight scale in provider analytics and tech-enabled services

  • Microsoft

    Broad healthcare data, AI, and BI platform overlap

  • Snowflake

    Cloud data platform rival for healthcare data unification and AI

  • Salesforce

    Health Cloud and CRM analytics for engagement and care workflows

CompareAfter hours

CompanyPriceChange
Health Catalyst$1.89+0.48%$133.7M0.5−12.7%
Oracle$149.15+0.00%$427.95B23.317.56.0+29.6%
UnitedHealth Group$373.10+0.05%$342.88B24.317.50.8+0.4%
Microsoft$497.65−0.08%$3.72T27.925.411.2+17.8%
Snowflake$336.27−0.07%$117.63B132.321.6+35.1%
Salesforce$233.06−0.08%$193.63B21.615.94.4+10.8%
Median23.817.56.0+17.8%